Ozempic, Wegovy and Mounjaro are the three names almost everyone runs into when they start looking into medical weight loss. They’re related but not interchangeable, and the right pick comes down to your goals, your medical history and what a doctor recommends after assessing you. Here’s a clear, side-by-side look at Mounjaro vs Ozempic vs Wegovy.
The quick summary
- Ozempic (semaglutide) – a GLP-1 medication approved mainly for type 2 diabetes; widely used and well established.
- Wegovy (semaglutide) – the same active ingredient as Ozempic, but dosed and approved specifically for weight management.
- Mounjaro (tirzepatide) – a newer dual GIP/GLP-1 medication that has posted the strongest average weight loss of the three in clinical trials.
How they work
Ozempic and Wegovy both contain semaglutide, which mimics the GLP-1 hormone to curb appetite and slow how fast your stomach empties. Mounjaro contains tirzepatide, which works on two hormone pathways, GIP as well as GLP-1, and that second lever is thought to explain its edge on weight loss.
Side effects
All three share a similar side-effect profile, most often nausea, reduced appetite and digestive changes, particularly when you start or step up the dose. These usually settle over time and are kept in check by titrating the dose slowly, with a doctor helping you manage them.
Which one is right for you?
There’s no single best medication, only the one that’s best for you. The right choice hinges on whether you have diabetes, how much weight you want to lose, how well you tolerate side effects, plus availability and cost. It’s a decision to make with a doctor who can assess your health and track your progress over time.
Frequently asked questions
Is Mounjaro better than Ozempic for weight loss?
On average, tirzepatide (Mounjaro) has shown greater weight loss than semaglutide (Ozempic) in studies, but the best option depends on your individual health profile and your doctor’s assessment.
What’s the difference between Ozempic and Wegovy?
They contain the same active ingredient, semaglutide. Ozempic is approved mainly for type 2 diabetes; Wegovy is dosed and approved specifically for weight management.
Can I switch between them?
Sometimes, under medical guidance. People may switch for tolerance, results or availability, but never switch or adjust dosing without your doctor.
This article is for general education and isn’t medical advice. These are prescription medicines that should only be used under the supervision of a qualified doctor.
Related
GLP-1 & Mounjaro treatment in Bali
Treatment: learn about GLP-1 / Mounjaro weight-loss treatment at Boost Health Clinic – doctor-led, in Jakarta, Bali and online across Indonesia.